T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.46 and traded as low as $0.11. T2 Biosystems shares last traded at $0.11, with a volume of 36,090 shares traded.
Analyst Ratings Changes
Separately, StockNews.com assumed coverage on T2 Biosystems in a report on Saturday. They issued a “sell” rating on the stock.
Check Out Our Latest Research Report on TTOO
T2 Biosystems Stock Performance
T2 Biosystems Company Profile
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
Read More
- Five stocks we like better than T2 Biosystems
- Energy and Oil Stocks Explained
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- How to invest in marijuana stocks in 7 steps
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- 10 Best Airline Stocks to Buy
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
